This is supported by studies suggesting that biomarkers related to endothelial cell activation (such VCAM-1) [16], glycocalyx lesion (syndecan-1) [17, 18] and endothelial growth factor (angiopoietin-2 and VEGF-1) [19–21] are associated with AKI. Here, VCAM1 is linked to acute kidney injury.